Shanghai Asia Pharmaceutical

Shanghai Asia Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing company based in Shanghai, China, that focuses on the production of chemical drug formulations. Established in 1994, the company has developed a diverse portfolio of generic medications targeting major therapeutic areas such as cardiovascular disease, metabolic disorders, and infectious diseases. Its key products include amlodipine besylate for hypertension, metformin for diabetes, and roxithromycin for bacterial infections. The company operates a large-scale, GMP-certified manufacturing facility in the Minhang District of Shanghai, producing various dosage forms including tablets, capsules, and granules. Shanghai Asia Pharmaceutical also maintains a dedicated research institute to support its product development and consistency evaluation efforts. The company was formerly a subsidiary of the Singapore-listed Asia Pharmaceutical Group and continues to be a significant player in the regional pharmaceutical market.